Verjee Rehan

SEC Form 4 insider trading activity

Verjee Rehan has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.

On the most recent filing, Verjee Rehan is listed as Director at Tyra Biosciences, Inc. Inside the rolling window, Verjee Rehan reported 1 open-market purchase totaling $20K in TYRA and no open-market sales.

Companies traded

Other insiders at TYRA

Insider Buying

$20K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TYRA
Verjee Rehan
Purchase$20KSep 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Verjee Rehan made?

Verjee Rehan has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Verjee Rehan trade?

Verjee Rehan has filed SEC Form 4 disclosures for 1 company, including TYRA.

When was Verjee Rehan's most recent SEC Form 4 filing?

Verjee Rehan's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.

What is Verjee Rehan's total buy and sell value in the current window?

Inside the rolling retention window, Verjee Rehan bought $20K and sold $0 based on SEC Form 4 filings.

What was Verjee Rehan's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 971.894 TYRA shares on 2026-09-09, worth $20K, per SEC Form 4 filings.